Blood Test Found Effective in Screening Down Syndrome In Twin Pregnancies

by Ramya Rachamanti on  June 6, 2019 at 7:01 PM Women Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

Cell-free DNA (cfDNA) testing for Down syndrome in twins is found to be as effective as in singletons with a detection rate of 98% and only a 0.05% rate of misdiagnosis, according to a new analysis published in Ultrasound in Obstetrics & Gynecology.
Blood Test Found Effective in Screening Down Syndrome In Twin Pregnancies
Blood Test Found Effective in Screening Down Syndrome In Twin Pregnancies

cfDNA testing involves analyzing fetal DNA in a maternal blood sample. It is a non-invasiveness and highly accurate test for Down syndrome in singleton pregnancies, but its effectiveness in twin pregnancies has been unclear.

Show Full Article


The analysis combined information from a dataset of 997 twin pregnancies in addition to results from seven previously published studies.

In many countries, including the United States, cfDNA testing is not recommended for use in twin pregnancies. These latest findings provide compelling evidence that mothers carrying twins should not be denied this safe and effective test.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive